Comparisons of different treatment options for Parkinson’s disease have previously been reported, although we could not identify any review comparing all dopamine agonists and MAO-B inhibitors available for treatment of Parkinson’s disease, both when used as monotherapy and in combination with levodopa. Here, MAOB is linked to Parkinson disease.